Search - tctmd.com

Displaying 121 - 140 of 900

Sort: Relevancy | Date

Presentation TCT 2020

TCT 319: Risk Stratification of All-Cause Mortality Using Resistive Reserve Ratio in Patients With No Obstructive Coronary Artery Disease

Presenter: Takumi Toya

October 14, 2020

Presentation TCT 2020

TCT 385: Placebo-Controlled Efficacy of Percutaneous Coronary Intervention for Focal and Diffuse Patterns of Stable Coronary Artery Disease: A Secondary Analysis From ORBITA

Presenter: Christopher Rajkumar

October 14, 2020

Presentation TCT 2020

TCT 390: Safety and Efficacy of Sirolimus-Eluting Stent System in All-Comers Real-World Population With Coronary Artery Stenosis: The MILES-Global Study

Presenter: Martin Hudec

October 14, 2020

Presentation TCT 2020

TCT 062: Short Term Dual Anti-Platelet Therapy Followed by P2Y12 Monotherapy After Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Control Trials

Presenter: Mohammad Saud Khan

October 14, 2020

Presentation TCT 2020

TCT 066: Ischemic and Bleeding Outcomes in Patients With vs. Without Atrial Fibrillation: Analysis From the Onyx ONE Month DAPT Program

Presenter: Sanjeevan Pasupati

October 14, 2020

Presentation TCT 2020

TCT 056: Prolonged Dual Antiplatelet Therapy in Patients With or Without Prior Myocardial Infarction: An Updated Systematic Review and Meta-Analysis

Presenter: Mauro Chiarito

October 14, 2020

Presentation TCT 2020

TCT 065: Cangrelor Use Patterns and Transition to Oral P2Y12 Inhibitors Among Patients With Myocardial Infarction: Early Results From the Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes (CAMEO) Registry

Presenter: Jennifer Rymer

October 14, 2020

Presentation TCT 2020

TCT 060: Contribution of ESC DAPT Guideline-Endorsed High Thrombotic Risk Features to Long-Term Clinical Outcomes Among Patients With and Without High Bleeding Risk After PCI

Presenter: Hao-Yu Wang

October 14, 2020

Presentation TCT 2020

TCT 057: Clinical Outcomes According to Lesion Complexity in High Bleeding Risk Patients Treated With 1-Month Dual Antiplatelet Therapy Following PCI: Analysis From the Onyx ONE Clear Study

Presenter: David Kandzari

October 14, 2020

Presentation TCT 2020

TCT 055: Short Duration of Dual Antiplatelet Therapy After PCI With DES: An Updated Meta-Analysis of Randomized Controlled Trials.

Presenter: Ahmed Elzanaty

October 14, 2020

Presentation TCT 2020

TCT 067: Antithrombotic Treatment Strategies in Patients Older than 75 Years With Atrial Fibrillation After Percutaneous Coronary Intervention With Drug-Eluting Stents. The PACO-PCI Registry

Presenter: Jose de la Torre Hernandez

October 14, 2020

Presentation TCT 2020

TCT 059: Meta-Analysis of Bleeding, MACE and Mortality in Clinical Trials of Time-Constrained Dual-Antiplatelet Therapy After PCI

Presenter: Jennifer Ramsay

October 14, 2020

Presentation TCT 2020

TCT 058: Evaluation of Antithrombotic Strategies Before and After the First Month of Therapy: Landmark Analysis of the RE-DUAL PCI Trial

Presenter: Benjamin Peterson

October 14, 2020

Presentation

Clopidogrel vs Ticagrelor or Prasugrel in Patients 70 Years or Older With NTSE ACS: POPular Age

April 27, 2020

Presentation ACC 2020

EPA Levels and Cardiovascular Outcomes in the Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial

Presenter: Deepak L. Bhatt

March 30, 2020

Presentation JIM 2020

Retrograde Bail-Out Strategy for Iatrogenic Dissection of the Right Coronary Artery

Presenter: Emily Mae Yap

February 15, 2020

Presentation JIM 2020

Ultra LOW LDL is the target for high risk patients

Presenter: Francesco Prati

February 13, 2020

Presentation JIM 2020

Caught between a rock and a hard place: Lithotripsy & Orbital Atherectomy

Presenter: Carlo Di Mario

February 13, 2020

Presentation JIM 2020

Benefits of hemodynamic stabilization during preparation of calcified lesions

Presenter: Carlo Briguori

February 13, 2020

Presentation

Association of Sex With Outcomes in Patients Undergoing PCI

January 31, 2020

Advertisement

TCT 319: Risk Stratification of All-Cause Mortality Using Resistive Reserve Ratio in Patients With No Obstructive Coronary Artery Disease

TCT 385: Placebo-Controlled Efficacy of Percutaneous Coronary Intervention for Focal and Diffuse Patterns of Stable Coronary Artery Disease: A Secondary Analysis From ORBITA

TCT 390: Safety and Efficacy of Sirolimus-Eluting Stent System in All-Comers Real-World Population With Coronary Artery Stenosis: The MILES-Global Study

TCT 062: Short Term Dual Anti-Platelet Therapy Followed by P2Y12 Monotherapy After Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Control Trials

TCT 066: Ischemic and Bleeding Outcomes in Patients With vs. Without Atrial Fibrillation: Analysis From the Onyx ONE Month DAPT Program

TCT 056: Prolonged Dual Antiplatelet Therapy in Patients With or Without Prior Myocardial Infarction: An Updated Systematic Review and Meta-Analysis

TCT 065: Cangrelor Use Patterns and Transition to Oral P2Y12 Inhibitors Among Patients With Myocardial Infarction: Early Results From the Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes (CAMEO) Registry

TCT 060: Contribution of ESC DAPT Guideline-Endorsed High Thrombotic Risk Features to Long-Term Clinical Outcomes Among Patients With and Without High Bleeding Risk After PCI

TCT 057: Clinical Outcomes According to Lesion Complexity in High Bleeding Risk Patients Treated With 1-Month Dual Antiplatelet Therapy Following PCI: Analysis From the Onyx ONE Clear Study

TCT 055: Short Duration of Dual Antiplatelet Therapy After PCI With DES: An Updated Meta-Analysis of Randomized Controlled Trials.

TCT 067: Antithrombotic Treatment Strategies in Patients Older than 75 Years With Atrial Fibrillation After Percutaneous Coronary Intervention With Drug-Eluting Stents. The PACO-PCI Registry

TCT 059: Meta-Analysis of Bleeding, MACE and Mortality in Clinical Trials of Time-Constrained Dual-Antiplatelet Therapy After PCI

TCT 058: Evaluation of Antithrombotic Strategies Before and After the First Month of Therapy: Landmark Analysis of the RE-DUAL PCI Trial

Clopidogrel vs Ticagrelor or Prasugrel in Patients 70 Years or Older With NTSE ACS: POPular Age

EPA Levels and Cardiovascular Outcomes in the Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial

Retrograde Bail-Out Strategy for Iatrogenic Dissection of the Right Coronary Artery

Ultra LOW LDL is the target for high risk patients

Caught between a rock and a hard place: Lithotripsy & Orbital Atherectomy

Benefits of hemodynamic stabilization during preparation of calcified lesions

Association of Sex With Outcomes in Patients Undergoing PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content